top of page
Search

Part 2 Reboot: What 2024’s Final Rule Really Changes—& What It Doesn’t

  • Writer: Laura Young
    Laura Young
  • Jul 23
  • 3 min read

Why another “new” Part 2 rule?

On Feb 16 2024 SAMHSA and the HHS Office for Civil Rights published the long-awaited final rule aligning 42 CFR Part 2 with key portions of HIPAA, as directed by the CARES Act. The rule took legal effect on April 16 2024, but regulated entities have until Feb 16 2026 to comply, giving providers, HIEs and vendors breathing room to update policies and technology. (Federal Register)

ree

Headline changes you should plan for

New Requirement

What It Means in Practice

Key Source

Single, broad patient consent for TPO

One consent now covers all future uses & disclosures for Treatment, Payment & Operations (TPO).

HIPAA-style redisclosure

HIPAA-style redisclosure for TPO. Covered entities and BAs that receive Part 2 data under that consent may redisclose it as HIPAA allows.

Stronger penalties & anti-discrimination

Civil/monetary penalties now mirror HIPAA; explicit bans on using SUD data to deny housing, employment, benefits, etc.

SUD-Counseling Notes carve-out

Detailed therapy notes get special protection—think “psychotherapy notes” under HIPAA.

Public-health sharing (de-identified)

You may share de-identified SUD data with public-health authorities—helpful for overdose dashboards.

Updated Notice of Privacy Practices

Covered entities must add Part 2 language to their NPPs.

Top misconceptions—busted

  1. “Part 2 is now just HIPAA—no consent needed.”

    Reality: A written patient consent is still the gatekeeper. The rule simply allows for a single, broad TPO consent. That very same consent now automatically covers all future uses & disclosures for Treatment, Payment & Health-care Operations (TPO). Without it, Part 2 records remain locked down. (HHS.gov)

  2. “Once I have the record, I can use it for anything.”

    Reality: Redisclosure is limited to TPO. Marketing, research, or legal uses still require a new consent—or a court order that meets Part 2 standards. (HHS.gov)

  3. “Part 2’s court-order protections disappeared.”

    Reality: The bar on using SUD records to investigate or prosecute patients has not changed, and specialized court-order rules remain. (HHS.gov)

  4. “State consent laws are pre-empted.”

    Reality: The rule does not override more stringent state laws. California, Maine, and others may still demand separate or more granular consent. Providers must map both layers.

  5. “We have to comply right now.”

    Reality: Compliance deadline is Feb 16 2026. Use the runway to update EHR segmentation, refresh consent language, and retrain staff. (Federal Register)


Action checklist for HIEs & providers

  1. Update consent workflows. Replace encounter-specific forms with a durable TPO consent that clearly references Part 2 & HIPAA.

  2. Refresh data-segmentation logic. Even with broader redisclosure, downstream systems still need to tag SUD data to honor opt-outs, litigation holds, or state laws.

  3. Revise Notices of Privacy Practices to include new Part 2 rights, penalties, and anti-discrimination language.

  4. Educate clinicians & support staff on when the initial consent is required and how redisclosure boundaries differ from ordinary HIPAA data.

  5. Engage your legal/compliance team now; the 2026 date will arrive fast once vendor upgrades, contract amendments, and outreach campaigns are factored in.

The big picture

The 2024 overhaul reduces some of the friction that has long siloed SUD data, but it doesn’t erase the patient-consent foundation or Part 2’s justice protections. For HIEs and care-coordination programs, the new flexibility is welcome—yet meaningful interoperability still depends on robust consent management, clear role-based access, and ongoing patient trust.

“Alignment with HIPAA is progress, but it’s not a free-for-all. Consent remains the cornerstone of stigma-free, patient-centered data exchange.” — Converge Health Policy Team

Need help navigating the 2024 Part 2 rule? Converge Health’s Last-Mile Interoperability practice can accelerate your consent redesign, data segmentation, and stakeholder training ahead of the 2026 deadline.



 
 
 

Comentários

Avaliado com 0 de 5 estrelas.
Ainda sem avaliações

Adicione uma avaliação
bottom of page